128 related articles for article (PubMed ID: 19156380)
21. The Comparison of Clinical Outcomes After Drug-Eluting Balloon and Drug-Eluting Stent Use for Left Main Bifurcation In-Stent Restenosis.
Lee WC; Hsueh SK; Chen CJ; Yang CH; Fang CY; Wu CJ; Fang HY
Int Heart J; 2018 Sep; 59(5):935-940. PubMed ID: 30101849
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary care center.
Ferreira AC; Peter AA; Salerno TA; Bolooki H; de Marchena E
Ann Thorac Surg; 2003 Feb; 75(2):485-9. PubMed ID: 12607658
[TBL] [Abstract][Full Text] [Related]
23. Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).
Frutkin AD; Lindsey JB; Mehta SK; House JA; Spertus JA; Cohen DJ; Rumsfeld JS; Marso SP;
JACC Cardiovasc Interv; 2009 Jul; 2(7):614-21. PubMed ID: 19628183
[TBL] [Abstract][Full Text] [Related]
24. Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions.
Al-Lamee R; Ielasi A; Latib A; Godino C; Mussardo M; Arioli F; Figin F; Piraino D; Carlino M; Montorfano M; Chieffo A; Colombo A
Am J Cardiol; 2011 Oct; 108(8):1055-60. PubMed ID: 21791332
[TBL] [Abstract][Full Text] [Related]
25. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry.
Brilakis ES; Wang TY; Rao SV; Banerjee S; Goldman S; Shunk K; Kar B; Holmes DR; Dai D; Chin CT; Harding TM; Roe MT
JACC Cardiovasc Interv; 2010 Oct; 3(10):1068-73. PubMed ID: 20965466
[TBL] [Abstract][Full Text] [Related]
26. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M
Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
Hougaard M; Thayssen P; Kaltoft A; Tilsted HH; Maeng M; Lassen JF; Thuesen L; Okkels Jensen L
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1035-42. PubMed ID: 24311384
[TBL] [Abstract][Full Text] [Related]
28. Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy.
Lee MS; Kobashigawa J; Tobis J
JACC Cardiovasc Interv; 2008 Dec; 1(6):710-5. PubMed ID: 19463388
[TBL] [Abstract][Full Text] [Related]
29. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and trends of POBA in current DES Era.
Moriya M; Ishiwata S; Fujimoto Y; Mitani H; Yamaguchi T; Ohno M
Cardiovasc Interv Ther; 2015 Oct; 30(4):315-9. PubMed ID: 25603774
[TBL] [Abstract][Full Text] [Related]
31. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry.
Jensen JK; Jensen LO; Terkelsen CJ; Lassen JF; Tilsted HH; Hansen KN; Maeng M; Thuesen L; Thayssen P
Catheter Cardiovasc Interv; 2013 Feb; 81(2):260-5. PubMed ID: 22511512
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous coronary intervention as an alternative to bypass surgery for unprotected LMCA stenosis.
Park SJ; Kim YH
Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1107-14. PubMed ID: 18793113
[TBL] [Abstract][Full Text] [Related]
33. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
34. Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions: a systematic review and meta-analysis.
Wiisanen ME; Abdel-Latif A; Mukherjee D; Ziada KM
JACC Cardiovasc Interv; 2010 Dec; 3(12):1262-73. PubMed ID: 21232720
[TBL] [Abstract][Full Text] [Related]
35. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
36. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
Roy P; Buch AN; Javaid A; Okabe T; Raya V; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Gevorkian N; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2008 Feb; 101(3):293-9. PubMed ID: 18237587
[TBL] [Abstract][Full Text] [Related]
37. HIV status and type of coronary stent placed in patients presenting with ST-elevation myocardial infarction.
Albaeni A; Harris C; Eid SM; Abougergi MS; Wright SM
Coron Artery Dis; 2017 May; 28(3):239-245. PubMed ID: 28288008
[TBL] [Abstract][Full Text] [Related]
38. [Off-label use of drug-eluting coronary stents].
Germing A; Lindstaedt M
Versicherungsmedizin; 2008 Sep; 60(3):118-21. PubMed ID: 18807342
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a policy of selective drug-eluting stent implantation for patients at high risk of restenosis.
Shugman IM; Idris H; Kadappu KK; Nguyen P; Taylor D; Rajaratnam R; Leung D; Hopkins AP; Lo S; Juergens CP; French JK
Heart Lung Circ; 2013 Jul; 22(7):523-32. PubMed ID: 23454032
[TBL] [Abstract][Full Text] [Related]
40. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
